SCHEMBL6978632

SCHEMBL6978632

Cc1ccc(NC(=O)c2cccnc2)cc1NC(=O)c1cccc(CN2CCN(C)CC2)c1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRAF P15056 7/20 0.70
EGFR P00533 5/20 0.70
HPGDS O60760 1/20 0.66
KIT P10721 10/20 0.65
CSF1R P07333 9/20 0.65
ABL1 P00519 5/20 0.60
BCR P11274 5/20 0.60
PDGFRA P16234 3/20 0.60
ERBB2 P04626 2/20 0.60
LCK P06239 2/20 0.60
FYN P06241 2/20 0.60
LYN P07948 2/20 0.60
PDGFRB P09619 2/20 0.60
FGR P09769 2/20 0.60
SRC P12931 2/20 0.60
NQO2 P16083 2/20 0.60
EPHA8 P29322 2/20 0.60
ABL2 P42684 2/20 0.60
FRK P42685 2/20 0.60
BLK P51451 2/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6782706 0.89 HPGDS (0.75) BRAFEGFRHPGDSKITCSF1R
SCHEMBL6780729 0.86 HPGDS (0.67) BRAFEGFRHPGDSKITCSF1R
SCHEMBL31721202 0.86 HPGDS (0.69) BRAFEGFRHPGDSKITCSF1R
SCHEMBL6967943 0.86 HPGDS (0.67) BRAFEGFRHPGDSKITCSF1R
SCHEMBL6973506 0.86 HPGDS (0.64) BRAFEGFRHPGDSKITCSF1R
SCHEMBL7677867 0.85 HPGDS (0.66) BRAFEGFRHPGDSKITCSF1R
SCHEMBL6966564 0.84 HPGDS (0.65) BRAFHPGDSKITCSF1RMAPT
SCHEMBL31721283 0.84 DDR1 (0.60) BRAFEGFRHPGDSKITCSF1R
SCHEMBL7681667 0.84 HPGDS (0.63) BRAFEGFRHPGDSKITCSF1R
SCHEMBL6239405 0.84 ABL1 (0.86) BRAFEGFRKITCSF1RABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1115707-B1 BENZAMIDE DERIVATIVES AND THER USE AS CYTOKINE INHIBITORS ASTRAZENECA AB (SE) 2003-11-12 EP disclosed
US-6455520-B1 TUMOR NECROSIS FACTOR AND INTERLEUKIN INHIBITORS; ANTIINFLAMMATORY AGENTS, ANTIALLERGENS; BONE DISORDERS ASTRA ZENECA AB (SE) 2002-09-24 US disclosed